LINC01518

Across TCGA pan-cancer cohorts, LINC01518 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC01518’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC01518 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01518 is over-expressed in tumor.

HNSC, LUAD, and BLCA are the cancer types where LINC01518 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01518 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+1.238	<.001	11	view →
LUAD	All	All	+0.462	<.001	8	view →
BLCA	All	All	+1.128	.013	7	view →
KIRP	All	All	+0.202	.003	6	view →
LUSC	All	All	+0.768	<.001	4	view →
BRCA	Female	All	+0.115	.003	4	view →
KIRC	Male	All	+0.065	.006	4	view →
PRAD	All	All	+1.673	<.001	2	view →
UCEC	All	All	+0.590	.015	2	view →
LIHC	All	All	+0.285	.012	2	view →
STAD	All	All	+0.350	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC01518–HNSC

Open the HNSC breakdown →